Nektar Therapeutics (NKTR)
68.58
-0.91
(-1.31%)
USD |
NASDAQ |
May 21, 16:00
68.55
-0.03
(-0.04%)
After-Hours: 19:59
Nektar Therapeutics Total Liabilities (Quarterly) : 187.06M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.38B |
| Aquestive Therapeutics, Inc. | 175.18M |
| Boston Scientific Corp. | 18.25B |
| Esperion Therapeutics, Inc. | 770.46M |
| Corcept Therapeutics, Inc. | 176.89M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 763.27M |
| Shareholders Equity (Quarterly) | 576.22M |
| Debt to Equity Ratio | 0.2489 |
| Current Ratio | 10.21 |
| Net Debt Paydown Yield | 0.82% |